Prognosis Prediction and Surgical Benefit Subgroup Analysis in Anal Squamous Cell Carcinoma Patients Undergoing Concurrent Chemoradiotherapy
ABSTRACT Background This study aimed to develop a nomogram to predict overall survival in anal squamous cell carcinoma (ASCC) patients undergoing chemoradiotherapy and to identify patients who may benefit from surgery. Methods Data from 4697 ASCC patients were extracted from the Surveillance, Epidem...
Saved in:
| Main Authors: | Quan Wang, Guangmin Wan, Lu Yang, Gang Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.71091 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgery, chemoradiotherapy, or chemoradiation plus immunotherapy: Treatment strategies for nonmetastatic anal squamous cell carcinoma
by: Fang He, et al.
Published: (2024-12-01) -
Chemoradiotherapy effcacy in squamous cell rectal cancer: a propensity score matched analysis
by: V. V. Murzo, et al.
Published: (2023-09-01) -
Understanding and considerations of radiation-induced rectal and anal injury after neoadjuvant chemoradiotherapy for rectal cancer
by: Zhu Xiaoming, et al.
Published: (2023-10-01) -
Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy
by: Xiao-Chun Wang, et al.
Published: (2025-07-01) -
Patient-reported outcomes after chemoradiotherapy for anal cancer
by: Kathinka Schmidt Slørdahl, et al.
Published: (2025-07-01)